| 2023-09-22 | class changed from VUS to disease-causing |
Variant NM_000492.4:c.350G>T
| Name | NM_000492.4:c.350G>T |
| Protein name | NP_000483.3:p.(Arg117Leu) |
| Genomic name (hg19) | chr7:g.117171029G>T UCSC |
| Genomic name (hg38) | chr7:g.117530975G>T UCSC |
| #Exon/intron | exon 4 |
| Legacy Name | R117L |
| Class | disease-causing |
| WT sequence | TATGACCCGGATAACAAGGAGGAAC G CTCTATCGCGATTTATCTAGGCATA |
| Mutant sequence | TATGACCCGGATAACAAGGAGGAAC T CTCTATCGCGATTTATCTAGGCATA |
![]() |
![]() | dbSNP rs78655421 |
![]() | ![]() |
| Reference | PMID | Splicing | mRNA level | Maturation | Localization | Channel fonction (Cl-) | Bicarbonate |
| Hammerle et al, 2001 | 11278813 | ✓ | ✓ | ✓ |
« ✓ » indicates the type of analysis performed and not the results
| Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
| IVA | yes | no | yes | no |
| TEZ-IVA | yes | no | yes | no |
| ELX-TEZ-IVA | yes | no | yes | no |
| VNZ-TEZ-DIVA | yes | no | yes | no |
clinical and functional data presented above are provided by Vertex
No patient found in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 2 |
|---|---|
| CF | 2 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| CF | 2702 | heterozygote | CF-causing - Trans |
| CF | 2703 | heterozygote | CF-causing - Trans |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|